For individuals carrying precancerous blood cell abnormalities that can evolve into multiple myeloma, dietary intervention may offer a scientifically-grounded strategy to delay malignant transformation. This represents a significant shift from purely monitoring these at-risk populations to actively intervening with lifestyle modifications that target specific biological pathways involved in cancer progression.
The NUTRIVENTION trial demonstrated that a structured high-fiber, plant-based dietary intervention in 23 participants with myeloma precursor conditions and elevated BMI produced measurable improvements across three interconnected biological systems. Participants experienced enhanced insulin sensitivity, increased gut microbiome diversity with favorable bacterial composition shifts, and reduced systemic inflammation alongside altered immune cell populations. Complementary mouse studies using the Vk*MYC model revealed that dietary fiber specifically increased short-chain fatty acid production, which reinvigorated antitumor immune responses and directly inhibited malignant cell growth—effects that occurred independently of weight loss or calorie restriction.
This research bridges nutritional intervention with cancer prevention in a particularly meaningful way. Multiple myeloma progression from precursor states like MGUS affects hundreds of thousands of adults who currently have limited prevention options beyond monitoring. The mechanistic clarity provided by the mouse studies—showing fiber's direct impact on the microbiome-immunity axis—elevates this beyond observational dietary associations. However, the small human cohort size and 24-week duration limit definitive conclusions about long-term cancer prevention. The intervention's feasibility and multi-system biological improvements suggest this approach warrants larger, longer-term validation studies, potentially establishing dietary fiber as a evidence-based tool for cancer interception in high-risk populations.